TBRG.NASDAQTrubridge, INC

8-K: TruBridge Announces Strong First Quarter 2025 Results, Exceeding Expectations

Sentiment:

Earnings Release


TruBridge reports a strong start to 2025 with Q1 results exceeding expectations, driven by positive trends in bookings and increased transparency in reporting.

Better than expectedThe company's Q1 2025 results exceeded expectations, with revenue, GAAP net income, and adjusted EBITDA all showing significant improvements compared to the prior year.

Summary

  • TruBridge, Inc. announced its financial results for the first quarter ended March 31, 2025.
  • Total revenue increased to $87.2 million, compared to $84.1 million in the same quarter of the previous year.
  • Recurring revenue accounted for 94% of the total revenue.
  • Financial Health revenue reached $56.1 million, representing 64% of TruBridge's total revenue, compared to $53.4 million in the prior year.
  • GAAP net income was $0.5 million, a significant improvement from a net loss of $1.9 million in the first quarter of 2024.
  • Non-GAAP net income increased to $5.2 million from $3.4 million.
  • Adjusted EBITDA rose to $18.2 million, compared to $10.3 million in the same period last year.
  • Total bookings were $22.0 million, slightly lower than the $23.6 million reported in the first quarter of 2024.
  • The company is now reporting bookings based on annual contract value (ACV) for increased transparency.
  • For the second quarter of 2025, TruBridge expects total revenue between $85.5 million and $87.5 million and adjusted EBITDA between $12.5 million and $14.5 million.
  • The full-year 2025 revenue guidance remains unchanged at $345 million to $360 million, while adjusted EBITDA guidance is revised upward to $60 million to $66 million from the previous $59 million to $66 million.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with improved financial performance, increased transparency, and upward revisions to adjusted EBITDA guidance. While there are some risks and challenges, the overall tone is optimistic and suggests a strong start to the year for TruBridge.

Positives

  • The company experienced revenue growth, with total revenue increasing to $87.2 million.
  • Recurring revenue remains strong, providing a stable revenue base.
  • Adjusted EBITDA significantly improved, indicating enhanced profitability.
  • GAAP net income turned positive, demonstrating improved financial performance.
  • The company is increasing transparency in its reporting by focusing on annual contract value (ACV) for bookings.
  • Debt was paid down, bringing the leverage ratio to 2.4x.
  • The company welcomed a new General Manager of the Financial Health business unit.

Negatives

  • Total bookings decreased slightly to $22.0 million from $23.6 million in the first quarter of 2024.
  • The company experienced a net loss in 2024 due to an error related to the reversal of revenue from customers that was recognized improperly during 2023.

Risks

  • The company faces risks related to market saturation, hospital consolidations, and unfavorable economic conditions.
  • Legislative and regulatory uncertainty in the healthcare industry could impact the company's performance.
  • Competition from companies with greater financial, technical, and marketing resources poses a challenge.
  • The company's reliance on offshore third-party resources and potential litigation could create risks.
  • Breaches of security and viruses in the company's systems could result in customer claims and harm to its reputation.
  • Failure to maintain customer satisfaction through new product releases free of undetected errors or problems could impact the company's performance.
  • The company's substantial indebtedness and restrictive terms of its credit agreement could impact its operations.
  • Macroeconomic conditions could have a material adverse effect on the company.

Future Outlook

For Q2 2025, TruBridge expects revenue of $85.5 million to $87.5 million and adjusted EBITDA of $12.5 million to $14.5 million; full-year 2025 revenue is projected at $345 million to $360 million, with adjusted EBITDA revised to $60 million to $66 million.

Management Comments

  • Chris Fowler, CEO, stated that the company is off to a strong start for 2025, delivering first quarter results that exceeded expectations.
  • Fowler noted positive trends in bookings, including significant expansion of scope in Financial Health and a competitor displacement in Patient Care.
  • Fowler mentioned the introduction of a new method for reporting bookings, focusing on annual contract value.
  • Fowler highlighted the payment down of additional debt, bringing the leverage ratio to 2.4x.
  • Fowler expressed confidence in the plan of action created by Merideth Wilson, the new General Manager of the Financial Health business unit, to ensure the continued smooth progression of the global workforce transition.
  • Fowler added that the team is dedicated to serving rural and community markets and advancing towards goals to drive long-term success.

Industry Context

TruBridge operates in the healthcare solutions industry, providing technology-first solutions to healthcare organizations. The company's focus on revenue cycle management (RCM) and electronic health record (EHR) product offerings aligns with the industry's trend toward data-driven solutions and improved financial and clinical outcomes. The company's emphasis on serving rural and community markets positions it to address the unique needs of these underserved areas.

Comparison to Industry Standards

  • Comparing TruBridge's performance to industry peers requires considering companies offering similar healthcare solutions, such as Cerner (now Oracle Health), Allscripts, and athenahealth.
  • TruBridge's recurring revenue of 94% indicates a strong and stable business model, which is a positive sign compared to companies with lower recurring revenue percentages.
  • The adjusted EBITDA margin of 20.9% in Q1 2025 is a significant improvement from 12.3% in Q1 2024, suggesting enhanced operational efficiency.
  • While total bookings decreased slightly, the shift to reporting annual contract value (ACV) provides greater transparency and comparability to industry standards.
  • The company's focus on serving rural and community markets differentiates it from some larger competitors that may prioritize larger healthcare systems.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
General Manager of Financial Health business unitN/AMerideth WilsonJanuary 2025New appointment

Stakeholder Impact

  • Shareholders will likely view the improved financial performance and increased transparency positively.
  • Employees may be encouraged by the company's strong start to the year and the new General Manager's plan of action.
  • Customers in rural and community markets will benefit from TruBridge's continued dedication to serving their unique needs.
  • Suppliers and creditors may gain confidence from the company's improved financial stability and debt reduction.

Next Steps

  • TruBridge will hold a conference call and live webcast on May 7, 2025, to discuss the first quarter 2025 results.
  • The company will continue to provide total bookings under both methodologies (ACV and TCV) for year-over-year comparability before fully transitioning to ACV in 2026.
  • The company will focus on driving long-term success by serving rural and community markets and advancing towards its goals.

Key Dates

DateDescription
March 17, 2025Filing of the 2024 Annual Report on Form 10-K with the SEC.
March 31, 2025End of the first quarter for which financial results are reported.
May 7, 2025Date of the press release and 8-K filing announcing Q1 2025 results; conference call to discuss results.

Keywords

TruBridge, Financial Health, Patient Care, Revenue Cycle Management, Healthcare Solutions, EBITDA, Bookings, Revenue, Financial Results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.